Frovatriptan is a medication approved to relieve symptoms of migraine headaches. It comes in the form of a tablet and is taken as soon as possible once a migraine starts. The medication works by causing the blood vessels in the head to return to their normal state after dilating during a migraine. Some of the most common side effects include tingling sensations, dizziness, and fatigue.

What Is Frovatriptan?

Frovatriptan succinate (Frova®) is a prescription medication that is used to treat migraine headaches. The drug will not help to prevent migraines, but it can help to treat a migraine that has already started.
(Click What Is Frovatriptan Used for? for more information, including possible off-label uses.)

Possible Side Effects

As with any medicine, there are possible side effects with frovatriptan. However, not everyone who takes it will experience side effects. In fact, most people tolerate the medication well. When side effects occur, in most cases they are minor and either require no treatment or can easily be treated by you or your healthcare provider.
The most common side effects of frovatriptan include:
  • Dizziness
  • Fatigue
  • Headaches
  • Abnormal sensations, such as tingling, burning, or pricking (paresthesia)
  • Flushing (redness of the skin, especially of the face)
  • Dry mouth
  • Hot or cold sensations
  • Bone pain
  • Upset stomach or heartburn
  • Chest pain.
(Click Frovatriptan Side Effects to learn about the specific side effects, including serious side effects to look out for. You can also read about other possible side effects by going to Frova and Heart Problems.)
Know the Signs - Concussion Safety

Frovatriptan (Frova)

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.